The effectiveness of immunotherapy using a streptococcal preparation, OK-432, was evaluated for cervical cancer. The 382 eligible patients were stratified by presence/absence of surgical operation and clinical stage, and then, in each stratum, were randomly divided into two groups: an O K 4 3 2 trea
Clinical value of immunotherapy for lung cancer by the streptococcal preparation OK-432
โ Scribed by Yoh Watanabe; Takashi Iwa
- Publisher
- John Wiley and Sons
- Year
- 1984
- Tongue
- English
- Weight
- 463 KB
- Volume
- 53
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Background: The preoperative intratumoral injection with ok-432 (picibanil, chugai pharmaceutical co., tokyo, japan), an immunomodulatory agent prepared from an attenuated strain of streptococcus pyogenes, activates the regional immune system and causes degeneration of cancer tissue in carcinoma
Background and Objectives: It is not clear whether postoperative inflammation affects the prognosis of malignant disease. Methods: We retrospectively reviewed the patients with non-small-cell lung cancer who underwent a complete resection at the National Kyushu Cancer Center from 1989 to 1996. For t
In experiments performed with tumor cells isolated from surgical specimens and lymphocytes collected at the time of surgery, tumor cells are often lysed by blood lymphocytes. Some of the effectors are present in the high-density T-cell subset. This population has little or no anti-K562 activity. For